Articles On Immutep (ASX:IMM)

Title Source Codes Date
Why Adbri, Costa, Delta Lithium, and Immutep shares are racing higher

The S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and dropped into the red. At the time of writing, the benchmark index is down 0.85% to 7,151.5. Four ASX shares that are not letting that stop them from rising today...

Motley Fool IMM 10 months ago
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metast...

SmallCaps IMM 10 months ago
Immutep (ASX:IMM) doses first patient in Europe for AIPAC-003 breast cancer trial

Immutep (IMM) enrols and doses its first patient at its European clinical site for its integrated Phase II/III AIPAC-003 trial The trial aims to evaluate the effectiveness of Immutep’s drug candidate, eftilagimod alpha (efti), in combi...

themarketherald.com.au IMM 10 months ago
Has the Webjet share price peaked or can it keep rising?

The Webjet Limited (ASX: WEB) share price has been on form this week. So much so, the online travel agent’s shares hit a new 52-week high on Wednesday. This means the company’s shares are now up almost 23% since the start of the year....

Motley Fool IMM 10 months ago
ASX Today: Stocks to watch on Thursday

The ASX is expected to fall today on the back of overnight losses across other global markets, namely Europe and the US. Here are some ASX-listed companies to watch out for on Thursday: The first patient in Immutep’s (IMM) AIPAC-003 p...

themarketherald.com.au IMM 10 months ago
Why are 2 high-flying Aussie billionaires buying this little-known ASX lithium stock?

ASX lithium share Delta Lithium Ltd (ASX: DLI) may not be a household name, but it appears it is attracting interest from billionaire investors. Delta Lithium shares have soared nearly 37% year to date and 44% in the last month. So what...

Motley Fool IMM 10 months ago
If your super is under $500,000 and you want to retire, you’ll want to read this

The average Australian’s superannuation balance leaves much to be desired for one seeking a comfortable retirement. Fortunately, there’s a solution. Let’s dive into what anyone hoping to enter retirement without a large super balance c...

Motley Fool IMM 10 months ago
5 things to watch on the ASX 200 on Thursday

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was out of form and dropped into the red. The benchmark fell 0.6% to 7,213.8 points. Will the market be able to bounce back from this on Thursday? Here are five things to watch: ASX 200...

Motley Fool IMM 10 months ago
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

Stockhead IMM 10 months ago
Here are the top 10 ASX 200 shares today

The S&P/ASX 200 Index (ASX: XJO) struggled in Wednesday’s session, falling 0.63% to close at 7,213.8 points. That was despite a strong performance from the S&P/ASX 200 Energy Index (ASX: XEJ), which lifted 0.7% on the back of ri...

Motley Fool IMM 10 months ago
Why Immutep, Leo Lithium, Playside, and Webjet shares are storming higher

The S&P/ASX 200 Index (ASX: XJO) has dropped into the red on Wednesday. In afternoon trade, the benchmark index is down 0.5% to 7,221.4 points. Four ASX shares that are not letting that hold them back are listed below. Here’s why th...

Motley Fool IMM 10 months ago
ASX Health Stocks: Patrys, Immutep jump after reports show drugs well tolerated

Patry receives positive toxicology reports on PAT-DX1 Immutep says triple combination trial of Efti shows it is well tolerated Clarity Pharma is now advancing to cohort 2   Patrys receives positive report Therapeutic antibody development...

Stockhead IMM 10 months ago
UBS and Credit Suisse nearing completion of merger: ASX 0.46% lower at noon

ShareCafeUBS and Credit Suisse nearing completion of merger: ASX 0.46% lower at noon by Peter Milios   At noon, the S&P/ASX 200 is 0.46 per cent lower at 7,226.50. The SPI futures are pointing to a fall of 28 points. The decline coincid...

ShareCafe IMM 10 months ago
Stocks of the Hour: Leo Lithium, Empire Energy, Immutep, Cauldron Energy

24 May 2023 - A snapshot of the stocks on the move featuring Leo Lithium (ASX:LLL), Empire Energy (ASX:EEG), Immutep (ASX:IMM) and Cauldron Energy (ASX:CXU).

FNN IMM 10 months ago
Stocks of the Hour: LLL, EEG, IMM, CXU

ShareCafeStocks of the Hour: LLL, EEG, IMM, CXU                    Leo Lithium (ASX:LLL) has announced that further drilling at their Goulamina Lithium Project has delivered thick, high grade mineralisation. MD Simon Hay commented, “W...

ShareCafe IMM 10 months ago
Immutep’s Positive FDA Talks and Strong Survival Data

ShareCafeImmutep’s Positive FDA Talks and Strong Survival Data Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the significance of recent announcements on the back of a recent surge in trading volume. Paul Sanger:...

ShareCafe IMM 10 months ago
ScoPo’s Powerplays: ASX health stocks rise, Immutep surges 46pc on trial results

ASX health stocks rise in the past five days in line with broader markets Immutep  surges 46% after positive Phase 2 results into lung cancer Avita Medical falls 28% in past five days despite reporting “solid Q1 FY23” results Healthcare a...

Stockhead IMM 10 months ago
ASX Health Stocks: FDA approves Imugene’s Phase 1 trial; Noxopharm says it can fight skin disease

Immutep gets US FDA clearance to start Phase 1 study Noxopharm says its Sofra platform is effective against inflammatory skin disease Epsilon Healthcare announced a new CEO   US FDA approves Imugene’s Phase 1 Immuno-oncology biotech Imug...

Stockhead IMM 10 months ago
ASX closes 0.52% higher as high iron ore price boosts bellwethers

ShareCafeASX closes 0.52% higher as high iron ore price boosts bellwethers by Peter Milios   At the closing bell, the S&P/ASX 200 was 0.52 per cent higher at 7,236.80. Nufarm (ASX:NUF) rallied 14.2 per cent to $6.05 after announcing a 7...

ShareCafe IMM 10 months ago
Closing Bell: Its a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises

S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec...

Stockhead IMM 10 months ago
Why has this ASX healthcare share exploded 50% in two days?

The S&P/ASX 200 Health Care (ASX: XHJ) index has slid 0.55% in the last two days, but this ASX healthcare share has defied the trend. The Immutep Ltd (ASX: IMM) share price has rocketed 51% from 23.5 cents at market close on 16 May to...

Motley Fool IMM 10 months ago
ASX up 0.59% after surprise jobs data

ShareCafeASX up 0.59% after surprise jobs data by Peter Milios   According to the Australian Bureau of Statistics, the economy experienced a loss of 4,300 jobs in the previous month, which was contrary to economists’ predictions of gaining...

ShareCafe IMM 10 months ago
Stocks of the Hour: LRS, EMH, G88, IMM

ShareCafeStocks of the Hour: LRS, EMH, G88, IMM                    Latin Resources (ASX:LRS) announced that drilling confirms that their Colina deposit has lithium pegmatites extending over 2KM. VP of Operations, Tony Greenaway commen...

ShareCafe IMM 10 months ago
Stocks of the Hour: Latin Res, European Metals, Golden Mile Res, Immutep

18 May 2023 - A snapshot of the stocks on the move featuring Latin Resources (ASX:LRS), European Metals (ASX:EMH), Golden Mile Resources (ASX:G88) and Immutep (ASX:IMM).

FNN IMM 10 months ago
Top 10 at 10: Which explorer just reeled in 52m at 3.65g/t gold?

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead IMM 10 months ago
Positive results for Immutep's cancer candidate in combination with MSD's Keytruda

Immutep (ASX:IMM) has reported positive results from a clinical trial of its LAG-3 immunotherapy in combination with MSD's PBS-listed anti-PD-1 therapy KEYTRUDA (pembrolizumab).

BiotechDispatch IMM 10 months ago
ASX Health Stocks: Rhythym Bio skyrockets 70pc after being granted UK CA Mark

Rhythm Biosciences surged 70pc this morning after being granted the UK CA Mark for ColoSTAT Anteris Tech was issued another patent in the US Immutep reported positive Phase 2 results   It’s a big day for medical diagnostics company Rhythm...

Stockhead IMM 10 months ago
ASX closes 0.45% lower as healthcare, tech and consumer staples suffer

ShareCafeASX closes 0.45% lower as healthcare, tech and consumer staples suffer by Peter Milios   On Tuesday, at the closing bell, the S&P/ASX 200 was 0.45 per cent lower at 7,234.70, as the healthcare, tech, and consumer staples sector...

ShareCafe IMM 10 months ago
RBA indicates more hikes may be necessary: ASX 0.15% lower at noon

ShareCafeRBA indicates more hikes may be necessary: ASX 0.15% lower at noon by Peter Milios   The Reserve Bank’s minutes for May indicate that the central bank is committed to reducing inflation. The Board expressed its determination to tak...

ShareCafe IMM 10 months ago
Stocks of the Hour: Spenda, Cettire, Immutep

16 May 2023 - A snapshot of the stocks on the move featuring Spenda (ASX:SPX), Cettire (ASX:CTT) and Immutep (ASX:IMM).

FNN IMM 10 months ago
Immutep (ASX:IMM) gains FDA support for registrational Efti trial in lung cancer

Immutep (IMM) gains the green light from the US FDA to move ahead with its late-stage clinical plans to treat first-line, non-small cell lung cancer (NSCLC) The trial will assess the efficacy of eftilagimod alpha (Efti) in combination wi...

themarketherald.com.au IMM 10 months ago
Stocks of the Hour: SPX, CTT, IMM

ShareCafeStocks of the Hour: SPX, CTT, IMM                    Building upon a 20-year commercial foundation, Capricorn Society has selected Spenda (ASX:SPX) as its preferred supplier to deliver the first phase of its Digital Service D...

ShareCafe IMM 10 months ago
Market Highlights: China to benefit from a possible US default, and 5 ASX small caps to watch today

The ASX is set to open modestly higher on Tuesday China is set to benefit from a possible US default as debt ceiling deadline looms US lawmakers urged to stick to categorising cryptos as securities, not commdities   The ASX is set to open...

Stockhead IMM 10 months ago
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Stockhead IMM 10 months ago
New approval for trial of Immutep's 'efti' with Merck's PD-L1 inhibitor

Immutep (ASX IMM) has received regulatory approval from the Paul-Ehrlich-Institut, German Federal Institute for Vaccines and Biomedicines, to initiate a new investigator-initiated trial of eftilagimod alpha.

BiotechDispatch IMM 10 months ago
ASX Today: Stocks to watch on Monday

The ASX is expected to open higher on a new week after gains continued across New York on Friday night in the aftermath of quarterly reporting season. Elsewhere, eyes are fixated on central banks across the world this week, with the RBA...

themarketherald.com.au IMM 10 months ago
Market Highlights: JPMorgan bids for First Republic, Exxon’s record profit, and 5 ASX small caps to watch on Monday

The ASX is poised to open higher on Monday, tracking Wall Street’s moves ExxonMobil reports record profits The Fed and RBA will make rates decisions this week   The ASX is poised to open higher on Monday, tracking Friday’s gains in New Yo...

Stockhead IMM 10 months ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead IMM 10 months ago
ASX Today: Stocks to watch on Thursday

The ASX is on Thursday expected to follow the US Dow Jones index, which declined overnight following another slump in the banking sector. The dip comes from troubles surrounding the First Republic Bank, which has seen its shares fall mor...

themarketherald.com.au IMM 11 months ago
Immutep announces initiation of Phase 2/3 trial of 'efti' in metastatic breast cancer

Immutep (ASX:IMM) has announced the initiation of the AIPAC-003 Phase 2/3 clinical trial of its eftilagimod alpha in combination with paclitaxel for treating metastatic HER2-neg/low breast cancer.

BiotechDispatch IMM 11 months ago
Lake Resources leads the way as ASX closes 0.27% higher

ShareCafeLake Resources leads the way as ASX closes 0.27% higher by Peter Milios   At the closing bell, the S&P/ASX 200 was 0.27 per cent higher at 7,381.50, led by gains in the financials and real estate sectors. Lake Resources (ASX:LK...

ShareCafe IMM 11 months ago
Tech leaders gain as ASX rises 0.3% at noon

ShareCafeTech leaders gain as ASX rises 0.3% at noon by Peter Milios   At noon, the S&P/ASX 200 is 0.30 per cent higher at 7,383.60. Nine out of the eleven sectors are trading higher today. Information technology is surging on the back...

ShareCafe IMM 11 months ago
Stocks of the Hour: SYA, ALA, LKE, IMM

ShareCafeStocks of the Hour: SYA, ALA, LKE, IMM                    On Friday, Sayona Mining (ASX:SYA) announced an update on their Definitive Feasibility Study confirming the North American Lithium operation with an NPV of A$2.2 billi...

ShareCafe IMM 11 months ago
Stocks of the Hour: Sayona Mining, Arovella Therapeutics, Lake Resources, Immutep

17 Apr 2023 - A snapshot of the stocks on the move featuring Sayona Mining (ASX:SYA), Arovella Therapeutics (ASX:ALA), Lake Resources (ASX:LKE) and Immutep (ASX:IMM).

FNN IMM 11 months ago
ASX Today: Stocks to watch on Monday

The ASX is expected to rise on a fresh week, with eyes on US earnings as companies prepare to report this week. Ahead of a new week and market opening in Australia, here are some ASX-listed companies to look out for during Monday’s trade...

themarketherald.com.au IMM 11 months ago
Dr Boreham’s Crucible: Radiopharm Theronostics

Dr Boreham’s Crucible: Radiopharm Theronostics By Tim Boreham ASX code: ((RAD)); NASDAQ code (proposed): RADX Share price: 14.5 cents Market cap: $49.15 million Shares on issue: 238,947,639 (100,000,000 more in ASX escrow) Chief executive o...

FNArena IMM 11 months ago
Immutep announces changes to its board of directors

Immutep (ASX:IMM), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune diseases, has announced that Lis Boyce has been appointed as a non-executive director.

BiotechDispatch IMM 11 months ago
Gains from materials and healthcare boost ASX 0.71% at noon

ShareCafeGains from materials and healthcare boost ASX 0.71% at noon by Peter Milios   At noon, the S&P/ASX 200 is 0.71 per cent higher at 7,172.90, with materials and healthcare sectors leading the gains. Syrah Resources (ASX:SYR), Blo...

ShareCafe IMM 11 months ago
Stocks of the Hour: NOVONIX, Immutep, Sayona Mining

31 Mar 2023 - A snapshot of the stocks on the move featuring NOVONIX (ASX:NVX), Immutep Limited (ASX: IMM; NASDAQ:IMMP) and Sayona Mining (ASX:SYA).

FNN IMM 11 months ago
Stocks of the Hour: NVX, IMM, SYA

ShareCafeStocks of the Hour: NVX, IMM, SYA                    NOVONIX (NASDAQ:NVX, ASX:NVX) announced that it has agreed to establish a joint venture with TAQAT to develop and produce anode materials for electric vehicle and energy st...

ShareCafe IMM 11 months ago